Experience

Davis Polk is advising the Merchant Banking Division of Goldman Sachs in connection with the preferred equity financing for the approximately $5.5 billion acquisition of Cabela’s…

Davis Polk is advising an ad hoc group of holders of the second-lien notes of Midstates Petroleum Company, Inc. in connection with Midstates Petroleum’s chapter 11 bankruptcy case in…

Davis Polk advised the initial purchasers in connection with BRF GmbH’s $500 million offering of 4.350% senior notes due 2026, which were issued pursuant to Rule 144A and Regulation S under…

Davis Polk advised AC Immune SA in connection with its $75.9 million U.S. initial public offering. AC Immune sold 6,900,000 of its common shares in the offering, which included 900,000…

Davis Polk advised Postal Savings Bank of China Co., Ltd. on its initial public offering and listing on the Main Board of The Stock Exchange of Hong Kong Limited and an international…

Davis Polk advised the joint bookrunners and joint lead managers on a Regulation S-only offering of $300 million aggregate principal amount of 2.25% senior notes due 2019 by Dongxing Voyage…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Hess Corporation of $1 billion principal amount of 4.30% notes due 2027 and $500 million principal amount…

Davis Polk advised the global co-coordinators and book-running lead managers on the INR 60.57 billion (approximately $908 million) initial public offering and listing on the Bombay Stock…

Davis Polk is advising Bats Global Markets, Inc. on its approximately $3.2 billion acquisition by CBOE Holdings, Inc. The transaction, which is expected to close in the first half of…

Davis Polk is advising Chemtura Corporation in connection with its approximately $2.5 billion acquisition by LANXESS AG. The transaction, which is expected to close around mid-2017, is…